Connect with us

Technology

OM1 Earns Frost & Sullivan’s 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms

Published

2 years ago

on

OM1’s innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI integration and highly personalized insights.

SAN ANTONIO, Sept. 18, 2024 /PRNewswire/ — Frost & Sullivan recently researched the real-world evidence analytics (RWE) solutions industry and, based on its findings, recognizes OM1 with the 2024 North American New Product Innovation Award. OM1 is a leading technology company with expertise in personalized medicine, evidence generation, and RWE research. The company leverages its next-generation AI platforms and research-grade longitudinal data to enable pharmaceutical companies, healthcare providers, and researchers to gain deeper insights into patient outcomes, disease progression, and treatment efficacy.

OM1’s innovative approach integrates multiple data sources into a cohesive, actionable dataset that enhances clinical decision-making and research effectiveness. The company’s solutions, such as OM1 Orion, OM1 Lyra, and OM1 Polaris, offer precise patient journey analysis, personalized real-time insights, and optimized clinical trial recruitment. By utilizing artificial intelligence (AI), these cutting-edge platforms process extensive clinical data that enables healthcare professionals to uncover hidden patterns, predict patient responses, and tailor treatment strategies to individual patient demands.

Moreover, OM1’s dedication to quality and compliance ensures that its data solutions meet the industry’s most stringent standards. The company’s focus on cost-effectiveness and traceability allows healthcare organizations to confidently rely on its platforms to boost research and clinical operations while adhering to regulatory requirements.

“OM1 ensures its data is fit for purpose by focusing on several key factors. This approach empowers clinicians with a sufficient representative population sample to understand and mitigate biases. The company also considers cost-effectiveness and compliance with the US FDA regulatory requirements, including traceability and auditability,” said Supriya Lal Kundu, healthcare industry analyst at Frost & Sullivan.

Through its strategic partnerships, OM1 has successfully expanded its reach and influence in the healthcare sector. By working with first-class pharmaceutical companies, healthcare providers, and research institutions, the company facilitates the development and implementation of breakthrough healthcare solutions tailored to each partner’s specific needs.

Additionally, OM1’s ability to integrate diverse datasets, such as electronic medical records (EMRs), pharmacy records, and patient-reported outcomes, allows its partners to conduct more accurate and comprehensive research. This focus on key partnerships and innovation positions OM1 as a trusted partner and a key player in the RWE solutions industry.

“OM1 dedicates resources to revolutionizing healthcare management and delivery, seeking partners who share its passion for innovation. The company’s secure, [HIPAA]-compliant collaboration with data partners driving groundbreaking research and precision healthcare, offering tangible returns on investment,” noted Samantha Fisher, best practices research analyst at Frost & Sullivan.

Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Ashley Shreve
ashley.weinkauf@frost.com

About OM1

OM1 is pioneering cutting-edge healthcare innovation through its insights-driven technology and data. It specializes in personalized medicine, evidence generation, and real-world evidence (RWE) research powered by next-generation AI platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. OM1 is led by a diverse group of scientists, engineers, researchers, and clinicians with over 30 years of experience in RWD/RWE. They have written the handbook on building clinical registries and developing the outcomes measure framework. OM1’s unprecedented innovation takes RWE from bench to practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.

Contact
Alyssa Horowitz
Om1@pancomm.com

 

SOURCE Frost & Sullivan

Related Topics:
Continue Reading

Technology

What to Look for in an Online GLP-1 Provider: Meant Outlines Five Questions Worth Asking Before Signing Up

Published

2 hours ago

on

November 7, 2026

By

MANASSAS, Va., Nov. 7, 2026 /PRNewswire/ — As more telehealth companies offer GLP-1 care, the options can look alike from the outside, and telling them apart takes more than a glance at a landing page. Meant is sharing five questions consumers can ask when choosing an online GLP-1 provider, along with how it approaches each one.

Five Questions Worth Asking

Who makes the clinical decisions? A trustworthy provider should be clear about which licensed clinicians review each person’s information. At Meant, those decisions are made by licensed providers through its clinical partner, OpenLoop Health.Is there a real evaluation first? Look for a health-history review before anything is prescribed, and for plain language that a prescription is never guaranteed. Meant’s online assessment covers health history, current medications, and goals.Can the company’s credentials be checked? Independent certifications are one signal consumers can verify for themselves. Meant displays the seal for its LegitScript certification on its website.Is it clear who fills prescriptions? Providers should be open about the pharmacies they work with and whether those pharmacies are licensed in the United States.Is ongoing support spelled out, limits included? Good providers explain what follow-up looks like and who handles which questions. Meant pairs care with an optional Care Coach, and medical questions go to the care team.

A certification is a transparency signal, not a government approval or a promise about results, and no checklist replaces a conversation with a licensed clinician. Meant does not diagnose or prescribe, and treatment is not guaranteed for every applicant.

Take a Closer Look

Consumers who want to see how the assessment, clinical oversight, and coaching fit together can visit Meant‘s website and compare the details against the questions above.

About Meant

Meant is a health and wellness technology company focused on personalized GLP-1 weight-care support delivered through telehealth. The platform combines an online clinical assessment, licensed oversight through OpenLoop Health, Care Coach support, and supplemental wellness resources. Meant does not itself diagnose or prescribe; clinical decisions are made by its clinical partners. Learn more at meant.health.

Meant Health, Inc.
support@meant.health
1-512-879-9187
10199 Dean Drive, Manassas, VA 20110, USA

View original content:https://www.prnewswire.com/news-releases/what-to-look-for-in-an-online-glp-1-provider-meant-outlines-five-questions-worth-asking-before-signing-up-302927805.html

SOURCE Meant

Continue Reading

Technology

Capturing the Beauty of Anhui through Images–2026 Anhui Photography Season Concludes

Published

4 hours ago

on

November 7, 2026

By

HUANGSHAN, China, Nov. 7, 2026 /PRNewswire/ — A news report from Crionline.

Spanning summer and autumn across three successive photography tours, the “Picturesque Anhui • Imaging Anhui” 2026 Anhui Photography Season officially wrapped up on November 4. Co-hosted by the Fédération Internationale de l’Art Photographique (FIAP), the Anhui Provincial Department of Culture and Tourism, and the Foreign Affairs Office of Anhui Provincial People’s Government, the event drew 116 photographers from 38 countries and regions. They visited 46 distinctive cultural and tourism attractions across five cities: Hefei, Chizhou, Anqing, Huangshan and Xuancheng. Through their lenses, they presented Anhui’s landscapes, cultural heritage and vibrant everyday life to the world.

Looking back on the three sessions: The first session kicked off in Hefei. Photographers documented the city’s innovation-driven urban landscape as well as the picturesque scenery and intangible cultural heritage of Chizhou’s ancient villages. The second session took them deep into Huangshan and Anqing. They explored time-honored Huizhou villages, magnificent mountains and Huangmei Opera culture, immersing themselves in Huizhou traditions and the cultural charm of the Yangtze River region in western Anhui. The concluding third session was held in Huangshan and Xuancheng, focusing on brilliant autumn hues, Huizhou‑style ancient architecture, and the traditional craftsmanship behind the Four Treasures of the Study.

From lush summer greens to rich autumn colours, the photographers produced more than 11,000 high‑resolution photographs. Reflecting the unique perspectives of international participants, these images will be disseminated globally in diverse forms. They will help tell compelling stories of Anhui’s cultural tourism and further boost the province’s international profile.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/capturing-the-beauty-of-anhui-through-images2026-anhui-photography-season-concludes-302932583.html

SOURCE Crionline

Continue Reading

Technology

JOYEE N01 Global Mass Production Launch and First Batch Delivery of 2,000 Overseas Orders Kicks Off

Published

5 hours ago

on

November 7, 2026

By

YANCHENG, China, Nov. 7, 2026 /PRNewswire/ — On October 28, the ceremony for the global mass production launch of the JOYEE N01 and the first batch delivery of 2,000 overseas orders was grandly held at the Yancheng Branch of China FAW. At the event, FAW Bestune delivered the first batch of 500 vehicles to African customers, marking the official entry of the JOYEE N01 into the global market.

As a flagship product, the BESTUNE XIAOMA has earned recognition from nearly 300,000 users since its launch in 2024. Built upon this blockbuster model and refined with a user-centric philosophy, the JOYEE N01 is an upgraded masterpiece — a solid step forward in elevating the user experience with a global vision.

The JOYEE N01 carries forward the adorable design language: rounded body lines paired with a rich array of exterior color options, winning over young families at first glance. All trims come standard with CATL batteries, delivering a maximum range of over 300KM. The four-door design ensures convenient access to the rear seats. In terms of safety, drawing on FAW’s 70-plus years of automotive manufacturing heritage, the vehicle is fully equipped with a high-strength steel body, dual front airbags, and an electronic stability control system. The product is scheduled to roll out in overseas markets one after another in the fourth quarter of 2026.

View original content:https://www.prnewswire.co.uk/news-releases/joyee-n01-global-mass-production-launch-and-first-batch-delivery-of-2-000-overseas-orders-kicks-off-302932578.html

Continue Reading

Trending